Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
- To assess the efficacy of docetaxel, cisplatin combination in terms of disease free
survival.
- Time to progression of the disease in terms of local and distant failure; assess the
survival time, and assess the objective (clinical and radiological) response rate and
the safety of the treatment.